MyoKardia Inc.

(MYOK) Trade

By |

Profile

MyoKardia Inc is a clinical stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

Contact Information

Website: www.myokardia.com
Main Phone: +1 650 741-0900
Address: 333 Allerton Avenue
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Anastasios Gianakakos
Employees: 102
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 56.80 $ 1.15 (2.07%)
Last Price 56.80 Change $ 1.15 Change % 2.07 Tick N/A
Bid 40.00 Bid Size 1,000.00 Ask 59.00 Ask Size 1,900.00
Open 55.75 High 57.00 Low 55.60 Prev Close 55.65
Last Trade Volume 203,346 52 Wk Hi 62.83 52 Wk Low 13.38
Market Cap 2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,966,061.00 EPS (TTM) -1.52 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 17 82
Number of Buys 7 24
Number of Sells 10 58
Net Activity -612 -15386926
Last 10 Buys Shares
Wendy L. Yarno 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Mark L. Perry 1,000
Jonathan C. Fox 1,000
Last 10 Sell Shares
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Jake Bauer 1,000
Jake Bauer 1,000
Anastasios Gianakakos 1,000
Anastasios Gianakakos 1,000
Jake Bauer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 83 83 83 83
Low Target Price Estimate 64 64 64 64
Mean Target Price Estimate 74 74 74 74
Standard Deviation 7.65 7.65 7.65 7.65
Date of Most Recent Estimate 05/21/18 05/21/18 05/21/18 05/21/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1